Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-31
2011-05-31
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S287000, C548S131000
Reexamination Certificate
active
07951813
ABSTRACT:
Disclosed are novel quinazolinone derivatives of formula:wherein:R1is optionally substituted phenyl or optionally substituted heteroaryl;R2is 3-hydroxy, 4-hydroxy, 3-NHR4or 4-NHR4, in which R4is hydrogen, —C(O)R5, —C(O)NHR6, or —SO2R6; in whichR5is optionally substituted lower alkyl or optionally substituted lower alkoxy; andR6is optionally substituted lower alkyl;R3is hydrogen, lower alkyl, lower alkoxy, or halo;V is oxygen, sulfur, or —NH—; andW is lower alkylene of 1-3 carbon atoms,which are useful as ALDH-2 inhibitors for treating mammals for various disease states, such as treatment for cocaine dependency and alcohol dependency.
REFERENCES:
patent: 5204369 (1993-04-01), Vallee et al.
patent: 5624910 (1997-04-01), Vallee et al.
patent: 5886028 (1999-03-01), Vallee et al.
patent: 6121010 (2000-09-01), Vallee et al.
patent: 6255497 (2001-07-01), Vallee et al.
patent: 7368434 (2008-05-01), Keung et al.
patent: 2005/0182045 (2005-08-01), Nagase et al.
patent: 2007/0270332 (2007-11-01), Vallee et al.
patent: 2008/0032995 (2008-02-01), Zablocki et al.
patent: WO-93/00896 (1993-01-01), None
patent: WO-03/106435 (2003-12-01), None
patent: WO-2005/032488 (2005-04-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Keung, W. et al. (1993) “Daidzin and Daidzein Suppress Free-choice Ethanol Intake by Syrian Golden Hamsters”Proc. Natl. Acad. Sci. USA(90): 10008-10012.
Int'l. Search Report mailed Sep. 9, 2008, Int'l. Application No. PCT/US2008/059304; Filing Date Apr. 3, 2008.
Abelman Matthew
Keung Wing Ming
Organ Michael
Tao Guoxin
Zablocki Jeff
Gilead Sciences, Inc.
Gilead Sciences, Inc.
Lewis Brian
Willis Douglas M
Wilson James O
LandOfFree
Quinazolinone derivatives as ALDH-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolinone derivatives as ALDH-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone derivatives as ALDH-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2686441